Depressive Disorders

116 soru

Soru 101Soru →

During a routine visit to an outpatient clinic, a 29-year-old woman reports a 2-month history of persistent sadness, tearfulness, and profound fatigue. She states she has lost interest in reading and hiking, activities she previously enjoyed every weekend. The patient notes she has been waking up at 3 AM daily and is unable to fall back asleep. She has lost 4 kg (8.8 lb) over this period without actively dieting. She denies any substance use or suicidal ideation. She has no significant past medical history and currently takes no medications. Her physical examination is unremarkable. The patient requests to be started on a medication to help her mood, noting that a family member had significant improvement with fluoxetine. Which of the following is the most appropriate next step in the clinical evaluation of this patient?

Cevabı ve açıklamayı göster

Cevap: Ascertain if the patient has experienced prior periods of abnormally elevated mood and increased goal-directed activity.

Cevap

The most appropriate next step is to ascertain if the patient has experienced prior periods of abnormally elevated mood and increased goal-directed activity.
The correct action is to screen for a history of abnormally elevated mood and increased goal-directed activity. This patient presents with a classic major depressive episode. However, before prescribing any antidepressant monotherapy (such as the requested fluoxetine), it is mandatory to screen for a past history of manic or hypomanic episodes. If a patient has a history of mania or hypomania, the underlying diagnosis is bipolar disorder. Prescribing an antidepressant without a concurrent mood stabilizer in a patient with bipolar disorder carries a significant risk of inducing a manic episode, commonly known as a manic switch.

Adım Adım Çözüm

1
Analyze the patient's presenting clinical symptoms.
The patient meets the diagnostic criteria for a major depressive episode based on low mood, anhedonia, early morning awakening, weight loss, and duration of 2 months.
To establish the current clinical syndrome requiring management.
2
Evaluate the patient's request for treatment.
The patient is requesting an antidepressant (fluoxetine) for her depressive symptoms.
To determine the potential risks and required screening before fulfilling the treatment request.
3
Determine the necessary safety screening prior to initiating antidepressant pharmacotherapy.
Screening for a history of manic or hypomanic episodes must be performed to differentiate unipolar depression from bipolar depression.
Antidepressant monotherapy in a patient with undiagnosed bipolar disorder can precipitate a dangerous manic switch.

Anahtar Kavram

Before initiating antidepressant monotherapy for a major depressive episode, clinicians must screen for a history of mania or hypomania to rule out bipolar disorder and prevent antidepressant-induced manic switching.
Soru 102Soru →

A 58-year-old woman is evaluated in the psychiatric clinic for a severe depressive episode characterized by profound sadness, anhedonia, early morning awakening, and significant weight loss. Over the course of the following year, her major depressive disorder proves difficult to manage, requiring a progressive escalation of her treatment plan due to varying degrees of treatment resistance. Her course ultimately culminates in a severe decompensation requiring urgent intervention. Arrange the following therapeutic steps in the most appropriate chronological sequence according to standard evidence-based treatment algorithms for major depressive disorder, from her initial presentation to the management of her final life-threatening deterioration.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for escalating treatment in major depressive disorder is: 1) Initiation of an SSRI at a standard dose, 2) Dose titration of the SSRI following a partial response, 3) Augmentation with an atypical antipsychotic after non-remission on a maximized dose, and 4) Electroconvulsive therapy (ECT) upon the development of severe psychotic features and food refusal.
The standard treatment algorithm for major depressive disorder begins with monotherapy using a first-line agent (SSRI, SNRI, bupropion, or mirtazapine). If the patient exhibits a partial response after an adequate trial (typically 4-6 weeks), the initial step is dose optimization. If the patient continues to experience significant residual symptoms despite an optimized dose, augmentation with another agent (such as an atypical antipsychotic) or switching to a different antidepressant class is indicated. Finally, for severe major depressive disorder complicated by life-threatening features (such as refusal to eat, acute active suicidality, or psychotic features), urgent electroconvulsive therapy (ECT) is the treatment of choice.

Adım Adım Çözüm

1
Identify the initial presentation of uncomplicated major depressive disorder.
The first step is initiating a first-line agent, such as an SSRI.
SSRIs are standard first-line therapies due to their favorable side-effect profiles and established efficacy.
2
Evaluate the management of a partial clinical response after an initial 4-week trial.
The next step is to maximize the dose of the current SSRI.
Dose optimization is the standard protocol when a patient shows partial improvement and tolerates the medication well, before switching or augmenting.
3
Determine the strategy for treatment-resistant depression when the maximized SSRI fails to achieve remission.
The subsequent step is augmentation with another agent, such as an atypical antipsychotic.
Augmentation or switching classes is indicated when an adequate trial of a maximized first-line agent remains ineffective.
4
Recognize the emergence of life-threatening and psychotic features.
The final step in this sequence is inpatient admission for ECT.
ECT is the gold-standard, rapid-acting treatment for depression complicated by mood-congruent delusions and severe food refusal.

Anahtar Kavram

Stepped-care pharmacological management and indications for electroconvulsive therapy (ECT) in major depressive disorder.
Soru 103Soru →

A 42-year-old man presents to the psychiatric clinic for the management of a newly diagnosed major depressive disorder (MDD). Over the next 18 months, his clinical course is characterized by significant treatment resistance, eventually leading to a severe exacerbation with psychotic features and food refusal. Arrange the following therapeutic interventions in the correct chronological order according to standard stepped-care pharmacologic and somatic treatment guidelines for MDD, starting from his initial presentation to his most severe exacerbation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of treatment escalation for major depressive disorder is: 1) initial SSRI/SNRI monotherapy, 2) switching to an alternative monotherapy upon non-response, 3) augmentation with a secondary agent (e.g., atypical antipsychotic) for partial response, and finally 4) electroconvulsive therapy for severe, treatment-resistant, or psychotic depression.
The correct sequence follows the evidence-based stepped-care model for MDD: initial monotherapy, switching monotherapies if there is no response, utilizing augmentation strategies if there is a partial response, and reserving electroconvulsive therapy for severe, refractory, or psychotic cases.

Adım Adım Çözüm

1
Identify the standard first-line treatment for uncomplicated MDD.
Initiation of SSRI monotherapy.
SSRIs have a favorable side effect profile and are the standard initial pharmacotherapy for MDD.
2
Determine the next step for a patient with zero response to an adequate initial trial.
Switching to a different antidepressant (e.g., SNRI).
Non-responders benefit more from switching to a different agent, whereas partial responders are candidates for augmentation.
3
Determine the management for a patient showing partial response to a subsequent monotherapy.
Augmentation with a second-generation antipsychotic or lithium.
Augmentation strategies build upon the partial efficacy of the current regimen to achieve remission in treatment-resistant cases.
4
Identify the definitive treatment for severe depression with life-threatening psychotic features.
Electroconvulsive therapy (ECT).
ECT provides rapid, highly effective relief for psychotic depression and when a patient's health is acutely compromised (e.g., food refusal).

Anahtar Kavram

The stepped-care approach to Major Depressive Disorder escalates from initial monotherapy, to switching agents for non-response, to augmentation for partial response, and ultimately to electroconvulsive therapy for refractory or psychotic depression.
Soru 104Soru →

A 36-year-old woman presents to the primary care clinic reporting a 5-week history of profound sadness, early morning awakening, decreased appetite, and difficulty concentrating at work. She states she has never felt this way before and denies any current suicidal ideation, hallucinations, or delusions. Her medical history is unremarkable, and she takes no medications. The physician determines she is experiencing a major depressive episode and considers initiating fluoxetine therapy. Which of the following is the most appropriate next step in the clinical care of this patient?

Cevabı ve açıklamayı göster

Cevap: Assess for a history of discrete periods characterized by abnormally elevated mood and impulsivity

Cevap

Assess for a history of discrete periods characterized by abnormally elevated mood and impulsivity.
The most important next step in evaluating a patient presenting with a major depressive episode is to screen for a history of manic or hypomanic episodes. A patient with a history of mania who is currently depressed has bipolar I disorder, not major depressive disorder. Differentiating between unipolar and bipolar depression is critical because the treatment algorithms differ significantly. Initiating antidepressant monotherapy (such as fluoxetine) in a patient with bipolar disorder is contraindicated because it can precipitate a manic episode (manic switch) and increase mood instability. Therefore, assessing for periods of elevated mood, impulsivity, and decreased need for sleep must occur before writing the prescription.

Adım Adım Çözüm

1
Diagnose the current episode
The patient meets criteria for a major depressive episode (at least 2 weeks of depressed mood/anhedonia plus associated symptoms like insomnia, weight loss, and poor concentration).
Establishing the current syndromal presentation is the first step in psychiatric evaluation.
2
Differentiate between unipolar and bipolar depression
The physician must actively screen for any past episodes of mania or hypomania.
A major depressive episode can occur in both Major Depressive Disorder (unipolar) and Bipolar Disorder. The treatments for these two conditions are fundamentally different.
3
Determine appropriate pharmacological safety
Initiating an SSRI (like fluoxetine) without ruling out bipolar disorder is unsafe.
Antidepressant monotherapy in a patient with undiagnosed bipolar disorder can precipitate a manic episode (manic switch) and lead to rapid cycling.

Anahtar Kavram

Prior to initiating antidepressant therapy for a depressive episode, patients must be screened for a history of mania or hypomania to avoid precipitating a manic episode.
Tahmini Süre:1m 15s
Soru 105Soru →

A 67-year-old man is evaluated by the consultation-liaison psychiatry team on the medical floor. He was admitted one week ago for a non-ST-elevation myocardial infarction and subsequently developed a complicated soft-tissue infection at the catheter insertion site, for which he is currently receiving intravenous linezolid. The nursing staff reports that the patient has been increasingly withdrawn, tearful, and refusing to participate in physical therapy. During the interview, the patient is fully oriented and demonstrates intact decision-making capacity. He reports a two-month history of a profoundly depressed mood, pervasive anhedonia, early morning awakenings, a 5-kg (11-lb) weight loss, and hearing a voice repeatedly telling him he is a "total failure." He states, "I just have no energy left to fight, but I definitely do not want any sort of shock treatments." His wife, who is present, privately tells the physician, "He doesn't know what he's saying. I give you full permission to do electroconvulsive therapy if it will fix this." Review of his past medical history reveals an episode at age 26 when he was hospitalized for a week after staying awake for five consecutive days and recklessly spending his life savings on an impulsive business venture. Which of the following is the most appropriate next step in the psychiatric management of this patient?

Cevabı ve açıklamayı göster

Cevap: Initiate quetiapine therapy

Cevap

Initiate quetiapine therapy
The patient's presentation of a major depressive episode with a historical manic episode confirms a diagnosis of Bipolar I Disorder, currently in a depressed phase with psychotic features. Quetiapine is a first-line, FDA-approved monotherapy for bipolar depression that will also target his auditory hallucinations. Importantly, it avoids the risk of inducing a manic switch (seen with traditional antidepressants), respects his competent refusal of ECT, and does not carry an absolute contraindication with linezolid (unlike SSRIs/SNRIs, which risk serotonin syndrome).

Adım Adım Çözüm

1
Analyze the psychiatric presentation and timeline.
The patient has a 2-month history of severe depression with psychotic features (auditory hallucinations).
Establishing the current syndrome is the first step in psychiatric diagnosis.
2
Screen past medical history for prior mood episodes.
The patient has a distinct history of a severe manic episode (hospitalization, decreased need for sleep, impulsivity) at age 26.
A single manic episode changes the diagnosis from Major Depressive Disorder to Bipolar I Disorder, fundamentally altering management.
3
Evaluate current non-psychiatric treatments for potential drug interactions.
The patient is receiving linezolid, an antibiotic that acts as a reversible, non-selective monoamine oxidase inhibitor (MAOI).
MAOIs combined with serotonergic agents (SSRIs, SNRIs) can cause fatal serotonin syndrome.
4
Assess the ethical and legal implications of the wife's request.
The patient has intact decision-making capacity and explicitly refuses electroconvulsive therapy (ECT).
Autonomy dictates that a competent patient's refusal of care supersedes a family member's wishes.
5
Select the optimal management strategy.
Quetiapine is selected.
As an atypical antipsychotic, it is first-line for bipolar depression, treats the psychotic features, avoids the risk of manic switch, and does not precipitate serotonin syndrome with linezolid.

Anahtar Kavram

Bipolar depression management requires avoiding antidepressant monotherapy due to manic switch risk; atypical antipsychotics effectively treat both mood and psychotic symptoms while respecting patient autonomy and avoiding critical pharmacological interactions.
Tahmini Süre:1m 30s
Soru 106Soru →

Match each clinical presentation of a depressive disorder to the most appropriate next step in management or targeted therapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 74-year-old retired teacher is brought to the emergency department. She has stopped eating for the past week, stating her 'stomach has turned to dust' as punishment for her sins. She exhibits severe psychomotor retardation and significant dehydration.
A 45-year-old executive reports a 6-week history of pervasive sadness, early morning awakenings, and a 6-kg (13-lb) weight loss. He is deeply troubled by his inability to sleep and poor appetite. He has no history of cardiac disease or seizures.
A 28-year-old graphic designer seeks treatment for low energy, poor concentration, and depressed mood. He recently stopped taking his prescribed sertraline due to severe anorgasmia, which caused significant marital distress.
A 31-year-old woman presents 8 weeks after delivering her first child. She reports feeling overwhelmed, tearful, and unable to enjoy time with her baby. She is exclusively breastfeeding and adamantly refuses all oral medications.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings align the patient with psychotic depression and food refusal to Electroconvulsive therapy, the patient with prominent insomnia and weight loss to Mirtazapine, the patient with SSRI-induced sexual dysfunction to Bupropion, and the medication-refusing postpartum patient to Interpersonal psychotherapy.
Each treatment choice addresses the specific nuances of the depressive episode. Electroconvulsive therapy is indicated for rapid response in psychotic depression with nutritional compromise. Mirtazapine targets depression accompanied by insomnia and weight loss. Bupropion is an effective antidepressant without serotonergic sexual side effects. Interpersonal psychotherapy is an evidence-based, non-pharmacological treatment suitable for mild-to-moderate peripartum depression.

Adım Adım Çözüm

1
Evaluate the severity, specific symptom profile, and side-effect intolerances of each patient's depressive episode.
Identified distinct presentations: psychotic depression with nutritional compromise, depression with insomnia/weight loss, SSRI-induced sexual dysfunction, and medication-averse peripartum depression.
Antidepressant therapy must be individualized based on clinical urgency, symptom clusters, and patient preference.
2
Match the clinical presentation to the treatment modality with the most appropriate mechanism of action or safety profile.
Matched the elderly patient to ECT, the executive to mirtazapine, the designer to bupropion, and the postpartum mother to psychotherapy.
To maximize therapeutic efficacy while minimizing adverse effects and ensuring patient safety.

Anahtar Kavram

Tailoring treatment for major depressive disorder based on symptom clusters (e.g., insomnia/weight loss, sexual dysfunction, psychotic features with imminent risk) and patient preferences (e.g., breastfeeding).
Soru 107Soru →

A son brings his 68-year-old mother to the geriatric psychiatry clinic due to a 6-week history of profound lethargy, worsening sadness, and uncharacteristic behavior. He reports that she now spends most of her day in bed and has lost 4.5 kg (10 lb) due to a near-total loss of appetite. During the interview, the patient repeatedly states that her internal organs are 'turning to dust' as a punishment for her past sins, and she mentions hearing a male voice that agrees with her. Her medical history includes severe osteoarthritis, for which she takes scheduled tramadol and acetaminophen. A review of her past psychiatric history reveals that at age 40, she experienced a 3-week episode characterized by a severely decreased need for sleep, rapid and pressured speech, and grandiose plans to start a nationwide business, which resulted in an involuntary psychiatric hospitalization. She was treated with medication at the time but discontinued it shortly after discharge and has not taken any psychiatric medications since. Vital signs are within normal limits. Physical examination is unremarkable. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Quetiapine

Cevap

The correct answer is to initiate quetiapine, as it is a first-line agent for bipolar depression that simultaneously addresses her psychotic features without interacting dangerously with tramadol.
The correct answer is to initiate quetiapine. This patient's presentation of a severe depressive episode (sadness, lethargy, weight loss) complicated by psychotic features (somatic delusions and auditory hallucinations), combined with a clear history of a manic episode, establishes the diagnosis of bipolar I disorder, current episode depressed with psychotic features. Quetiapine is a second-generation antipsychotic that has demonstrated efficacy as a first-line monotherapy for bipolar depression. It provides the necessary mood stabilization while simultaneously targeting her acute psychotic symptoms. Furthermore, unlike traditional antidepressants, quetiapine does not carry a significant risk of inducing serotonin syndrome when co-administered with her current analgesic, tramadol.

Adım Adım Çözüm

1
Evaluate the patient's psychiatric history to establish a baseline diagnosis.
The history of a 3-week episode of decreased sleep, pressured speech, and grandiosity requiring hospitalization confirms a diagnosis of bipolar I disorder.
Recognizing a history of mania is critical to differentiating unipolar depression from bipolar depression and avoiding inappropriate monotherapy.
2
Assess the current clinical presentation.
The patient is experiencing a major depressive episode with psychotic features, evidenced by somatic delusions (organs 'turning to dust') and auditory hallucinations.
Identifying the severity and presence of psychotic features determines the specific class of psychiatric medication required.
3
Review current medications for potential adverse interactions.
The patient is taking tramadol, a weak opioid agonist that also inhibits serotonin reuptake. Adding another strong serotonergic agent risks serotonin syndrome.
Polypharmacy in geriatric patients requires careful screening for drug-drug interactions, particularly regarding serotonergic load.
4
Select the most appropriate pharmacotherapy.
Quetiapine is selected because it is a first-line agent for bipolar depression, treats her psychotic features, and does not have a severe serotonergic interaction with tramadol.
An ideal agent must safely address both mood and psychosis concurrently.

Anahtar Kavram

Differentiating unipolar from bipolar depression with psychotic features and selecting appropriate pharmacotherapy while avoiding drug-drug interactions.
Tahmini Süre:1m 30s
Soru 108Soru →

A 32-year-old woman is evaluated in the psychiatry clinic for ongoing management of major depressive disorder. She initially presented two years ago with a 3-month history of pervasive sadness, anhedonia, significant weight loss, and severe insomnia leading to functional impairment at work. Over the course of her illness, she has required progressive escalation of her treatment regimen due to inadequate responses. Arrange the following therapeutic interventions in the generally accepted chronological sequence that her physician would have followed, from initial diagnosis to the management of severe, treatment-resistant symptoms.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Initiation of an SSRI -> Switch to an SNRI monotherapy -> Augmentation with an atypical antipsychotic -> Referral for electroconvulsive therapy (ECT).
The standard stepped-care algorithm for major depressive disorder dictates starting with a single first-line agent, typically an SSRI. If the patient exhibits no response after an adequate trial, switching to a different monotherapy (such as an SNRI) is indicated. If there is persistent non-response or only a partial response after multiple sequential monotherapy trials, augmentation with an atypical antipsychotic, lithium, or a second antidepressant is appropriate. Finally, if the depression remains severely treatment-resistant despite these medication combinations, neuromodulation therapies such as electroconvulsive therapy (ECT) are considered.

Adım Adım Çözüm

1
Identify the first-line treatment for a new diagnosis of major depressive disorder.
Initiation of an SSRI.
SSRIs have a favorable side effect profile and proven efficacy, making them the standard initial choice.
2
Determine the appropriate management for an initial medication non-response.
Switch to an SNRI monotherapy.
When a patient shows no clinical response to a first-line agent, the standard algorithm recommends switching to a different monotherapy rather than immediately adding medications.
3
Select the strategy for continued non-response or partial response after multiple monotherapy trials.
Augmentation with an atypical antipsychotic.
Adding a second medication with a different mechanism of action is appropriate when monotherapies have been exhausted or yield insufficient improvement.
4
Identify the ultimate intervention for severe, refractory cases.
Referral for electroconvulsive therapy (ECT).
ECT is highly effective and is utilized when patients remain severely symptomatic despite multiple combination pharmacological regimens.

Anahtar Kavram

Stepped-care pharmacological escalation for major depressive disorder
Tahmini Süre:1m 30s
Soru 109Soru →

A 31-year-old accountant visits the family medicine clinic accompanied by his partner. He reports a 5-week history of profound sadness, decreased energy, and difficulty concentrating. He states that he sleeps up to 14 hours a day and has gained 6 kg (13 lbs) over the past month. He describes a persistent sensation that his arms and legs are "weighed down by lead." His partner notes that his mood occasionally brightens for a few hours when they go out to his favorite restaurant, but he quickly reverts to feeling depressed. He has missed several days of work. He has no significant past medical history. Family history is notable for a mother who was hospitalized multiple times for erratic behavior and severe mood swings. Physical examination and basic laboratory studies, including thyroid function tests, are within normal limits. The physician determines that the patient is experiencing a major depressive episode. Which of the following is the most critical next step in management prior to initiating pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Elicit a history of distinct periods of decreased need for sleep and increased goal-directed activity

Cevap

The most critical next step is to elicit a history of distinct periods of decreased need for sleep and increased goal-directed activity to screen for a history of hypomania or mania.
This patient is experiencing a major depressive episode with atypical features, which include mood reactivity, hypersomnia, hyperphagia, and leaden paralysis. Atypical features, combined with a strong family history of erratic behavior and psychiatric hospitalizations, significantly increase the pre-test probability that this depressive episode is a manifestation of bipolar disorder rather than unipolar major depressive disorder. Before establishing a diagnosis of unipolar depression and initiating pharmacological treatment, it is absolutely critical to screen for a history of mania or hypomania (e.g., decreased need for sleep, grandiosity, increased goal-directed activity). Prescribing an antidepressant to a patient with unrecognized bipolar disorder can precipitate a dangerous manic switch.

Adım Adım Çözüm

1
Analyze the patient's specific depressive symptoms and historical context.
The patient presents with a major depressive episode characterized by atypical features (hypersomnia, hyperphagia/weight gain, leaden paralysis, and mood reactivity) alongside a family history highly suspicious for bipolar disorder.
Identifying these specific subtype features is crucial because atypical depression has a high correlation with bipolar disorder.
2
Determine the diagnostic requirements for major depressive disorder.
The DSM-5 criteria for major depressive disorder explicitly require that there has never been a manic or hypomanic episode.
Unipolar depression and bipolar depression share depressive symptoms but require completely different pharmacological approaches.
3
Identify the risk associated with the next management step.
Before initiating any pharmacotherapy, the physician must screen for past manic/hypomanic episodes to avoid prescribing an antidepressant monotherapy.
Treating unrecognized bipolar depression with a selective serotonin reuptake inhibitor (SSRI) or other antidepressant monotherapy carries a high risk of inducing a manic switch.

Anahtar Kavram

Patients presenting with a major depressive episode—especially those with atypical features (hypersomnia, weight gain, leaden paralysis, mood reactivity) and a family history of mood disorders—must be carefully screened for past manic or hypomanic episodes before initiating antidepressant therapy to prevent an iatrogenic manic switch.
Tahmini Süre:1m 0s
Soru 110Soru →

A 2828-year-old woman, who is at 1010 weeks gestation in her first pregnancy, presents to the psychiatric clinic with a 44-week history of overwhelming sadness, excessive sleeping up to 14 hours14\text{ hours} a day, and a sensation that her arms and legs are "weighed down by lead." She experiences daily crying spells and profound guilt over her lack of excitement regarding the pregnancy. She mentions that her primary care physician prescribed fluoxetine 33 weeks ago, but she discontinued it yesterday because she felt it was completely ineffective. Vital signs are within normal limits. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 0.2 \muU/mL0.2\text{ \mu U/mL} (normal non-pregnant: 0.50.5-5.0 \muU/mL5.0\text{ \mu U/mL}) and a free thyroxine (T4) level of 1.1 ng/dL1.1\text{ ng/dL} (normal: 0.90.9-1.7 ng/dL1.7\text{ ng/dL}). Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Assess for a history of episodes characterized by racing thoughts and excessive energy

Cevap

Assess for a history of episodes characterized by racing thoughts and excessive energy
This patient is experiencing a major depressive episode with atypical features (hypersomnia, leaden paralysis). A critical standard of care in psychiatry is to screen every patient presenting with depression for a past history of manic or hypomanic episodes before initiating antidepressant therapy. Atypical depressive features are highly correlated with bipolar depression. Prescribing antidepressant monotherapy to a patient with unrecognized bipolar disorder can precipitate a severe manic switch or rapid cycling.

Adım Adım Çözüm

1
Analyze the patient's psychiatric presentation.
The patient meets criteria for a major depressive episode with atypical features (hypersomnia, leaden paralysis).
Establishing the current syndromic diagnosis guides the pharmacological approach.
2
Evaluate the patient's medication history.
The patient engaged in premature drug discontinuation of fluoxetine after only 33 weeks, which has a very long half-life.
Recognizing the short trial duration prevents incorrectly labeling the episode as treatment-resistant, and noting the specific drug (fluoxetine) informs future drug interaction risks.
3
Interpret the laboratory findings in the context of her pregnancy.
The mildly suppressed TSH with normal free T4 is a normal physiologic finding at 1010 weeks gestation due to hCG cross-reactivity.
This rules out an underlying endocrine pathology as the cause of her symptoms.
4
Determine the necessary diagnostic prerequisite before prescribing a new treatment.
The physician must screen for a history of mania or hypomania.
Antidepressant monotherapy in an unrecognized bipolar patient can precipitate a severe manic switch.

Anahtar Kavram

In patients presenting with a major depressive episode, particularly those with atypical features, screening for a history of manic or hypomanic episodes is a mandatory prerequisite before prescribing antidepressant therapy.
Tahmini Süre:1m 30s
Soru 111Soru →

A 24-year-old medical student is diagnosed with a first episode of major depressive disorder. After ruling out any history of mania or hypomania, the physician prescribes a selective serotonin reuptake inhibitor (SSRI). The physician provides comprehensive anticipatory guidance regarding the expected treatment timeline. Arrange the following clinical events in the standard chronological order of their expected occurrence during a successful, uncomplicated course of SSRI therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence of events during SSRI therapy is: 1) Onset of transient adverse effects, 2) Improvement in neurovegetative symptoms, 3) Improvement in subjective mood, 4) Achievement of maximal therapeutic benefit, and 5) Initiation of a gradual taper after at least 6 months of remission.
The timeline of SSRI therapy follows a highly predictable clinical course. Initially, the acute increase in synaptic serotonin causes side effects (e.g., gastrointestinal distress, agitation) within hours to days. By weeks 1 to 2, neurovegetative symptoms such as sleep, appetite, and energy begin to improve. By weeks 4 to 6, neuroplastic changes and the downregulation of inhibitory autoreceptors lead to an improvement in subjective mood and anhedonia. Full remission may take 8 to 12 weeks to achieve. Once remission is achieved, clinical guidelines mandate a 'continuation phase' of at least 6 months for a first depressive episode before any gradual tapering is initiated to minimize the risk of relapse.

Adım Adım Çözüm

1
Identify the immediate physiologic response to SSRI initiation.
Side effects such as GI distress and jitteriness occur in the first few days.
Immediate increases in synaptic serotonin affect peripheral and central nervous system receptors prior to any adaptive downregulation.
2
Determine the first domain of clinical improvement.
Neurovegetative symptoms (energy, sleep, appetite) improve during weeks 1 to 2.
Physical symptoms respond faster than cognitive/emotional symptoms. This mismatch can lead to a transient increase in suicide risk as energy returns before mood improves.
3
Establish the timeline for subjective emotional improvement.
Subjective mood and anhedonia improve during weeks 4 to 6.
Emotional regulation requires long-term neurobiological adaptations, including autoreceptor downregulation and increased brain-derived neurotrophic factor (BDNF) expression.
4
Recognize the peak of the treatment response.
Full remission and maximal therapeutic benefit are achieved between weeks 8 and 12.
Some patients require extended time at a therapeutic dose to reach complete remission.
5
Apply standard guidelines for the discontinuation of therapy.
A taper is initiated only after a 6-month continuation phase.
Continuing medication for 6 to 9 months after remission of a first episode is standard of care to prevent early relapse.

Anahtar Kavram

The typical clinical timeline of SSRI response and treatment phases in Major Depressive Disorder.
Soru 112Soru →

A 6565-year-old retired firefighter is brought to the outpatient clinic by his husband. For the past 55 weeks, the patient has experienced a pervasive low mood, early morning awakenings, and a lack of interest in his previously beloved woodworking projects. He has lost 55 kg (1111 lb) during this period. The symptoms started roughly 22 weeks after he suffered an uncomplicated myocardial infarction. He says, "My life is essentially over; there is nothing to look forward to." Past medical history includes hypertension and the recent myocardial infarction. Thirty-five years ago, he experienced an episode of paranoia and auditory hallucinations that lasted for 1414 days and resolved completely without any subsequent psychotic symptoms. Current medications include aspirin, ticagrelor, metoprolol, rosuvastatin, and linezolid, which was started 44 days ago for a methicillin-resistant Staphylococcus aureus skin infection. The patient's advance directive designates his sister as his healthcare proxy. He is alert, oriented, and demonstrates a clear understanding of his diagnosis and treatment options. His husband pulls the physician aside and says, "He is too sad to think straight; I am his spouse, so I authorize you to prescribe whatever strong medication he needs right now." The physician concludes that the patient is experiencing a major depressive episode. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Inquire about prior episodes characterized by unusually high energy, grandiosity, and reduced sleep

Cevap

Inquire about prior episodes characterized by unusually high energy, grandiosity, and reduced sleep
Before initiating antidepressant monotherapy for a major depressive episode, it is critical to rule out a history of bipolar disorder. Unopposed antidepressants (such as SSRIs) can precipitate a manic or hypomanic episode in patients with bipolar depression. Therefore, the physician must inquire about prior episodes of elevated mood, impulsivity, and decreased need for sleep to ensure safe pharmacotherapy.

Adım Adım Çözüm

1
Evaluate the patient's presenting symptoms and timeline.
The patient meets the diagnostic criteria for a major depressive episode (depressed mood, anhedonia, weight loss, insomnia) lasting more than 22 weeks.
To establish the primary psychiatric syndrome requiring intervention.
2
Review the patient's past psychiatric history and current medication list.
The history reveals a resolved brief psychotic disorder and current linezolid use, but no documented screening for bipolar disorder.
To identify contraindications or necessary prerequisites before starting pharmacotherapy.
3
Determine the safest next clinical action before initiating standard depression treatment.
Screening for past hypomanic or manic episodes must be performed to differentiate unipolar from bipolar depression.
Antidepressant monotherapy in bipolar depression can induce a dangerous manic switch.

Anahtar Kavram

All patients presenting with a major depressive episode must be carefully screened for a history of mania or hypomania to rule out bipolar disorder before initiating unopposed antidepressant therapy.
Tahmini Süre:1m 30s
Soru 113Soru →

Match each patient's clinical presentation with the most appropriate initial pharmacological intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 78-year-old woman with a 6-week history of depressed mood, profound insomnia, and an unintentional 4-kg (8.8-lb) weight loss.
A 55-year-old man with a 2-month history of anhedonia, low mood, and severe bilateral burning foot pain due to long-standing diabetes mellitus.
A 34-year-old woman with a 3-month history of depressed mood, profound fatigue, and weight gain, who explicitly requests a treatment that will not cause sexual dysfunction.
A 45-year-old man with a 4-week history of severe depression, psychomotor retardation, and a fixed belief that his internal organs are rotting.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 78-year-old woman with insomnia/weight loss matches with mirtazapine. The 55-year-old man with diabetic neuropathy matches with duloxetine. The 34-year-old woman avoiding sexual dysfunction matches with bupropion. The 45-year-old man with somatic delusions matches with sertraline and olanzapine.
The correct matches align the unique pharmacologic profiles (including mechanism of action and common adverse effects) of specific medications with each patient's clinical needs. Mirtazapine provides targeted relief for insomnia and anorexia. Duloxetine addresses both mood and neuropathic pain. Bupropion avoids sexual side effects while mitigating fatigue. A combination of an antidepressant and antipsychotic is mandated for psychotic depression.

Adım Adım Çözüm

1
Analyze the 78-year-old woman's symptom cluster.
Identify prominent insomnia and weight loss in the setting of depression.
Mirtazapine is uniquely suited for this profile due to its side effects of appetite stimulation and sedation.
2
Analyze the 55-year-old man's comorbidities.
Identify concurrent major depressive disorder and painful diabetic neuropathy.
SNRIs like duloxetine offer dual efficacy, treating both the psychiatric and neurologic symptoms simultaneously.
3
Analyze the 34-year-old woman's treatment preferences and symptoms.
Identify fatigue, weight gain, and a strong desire to avoid sexual side effects.
Bupropion avoids the sexual dysfunction and weight gain typically seen with SSRIs, and provides an activating effect.
4
Analyze the 45-year-old man's clinical presentation.
Identify the presence of delusions (rotting organs), indicating major depressive disorder with psychotic features.
Antidepressant monotherapy is insufficient; standard management requires combining an antidepressant with an antipsychotic.

Anahtar Kavram

Tailoring pharmacotherapy for major depressive disorder based on patient-specific symptom clusters, medical comorbidities, and desired side-effect profiles.
Tahmini Süre:1m 30s
Soru 114Soru →

A university student, aged 22, presents to the campus health center complaining of an 8-week history of profound melancholy, excessive sleepiness, and a complete inability to concentrate. She explains that she has stopped attending her lectures and feels devoid of any motivation. Review of her medical records reveals a prior psychiatric admission two years ago; during that time, she remained awake for six consecutive days, exhibited grandiose delusions about leading the university, and engaged in highly disruptive activities on campus before being hospitalized. She is currently not taking any medications. Recent thyroid function tests show a thyroid-stimulating hormone (TSH) level of 2.5μU/mL2.5 \mu\text{U/mL} (normal: 0.4−4.0μU/mL0.4-4.0 \mu\text{U/mL}) and a free thyroxine (T4T_4) level of 0.9 ng/dL0.9 \text{ ng/dL} (normal: 0.8−1.8 ng/dL0.8-1.8 \text{ ng/dL}). She insists on being prescribed a medication to lift her mood so she can return to her studies. Which of the following is the most appropriate management plan for this patient?

Cevabı ve açıklamayı göster

Cevap: Commence therapy with quetiapine

Cevap

Commence therapy with quetiapine
The patient is currently presenting with a major depressive episode. However, her history of an episode characterized by decreased need for sleep, grandiosity, and hospitalization lasting six days unequivocally establishes a diagnosis of bipolar I disorder. The first-line pharmacological treatment for bipolar depression includes specific atypical antipsychotics (such as quetiapine or lurasidone) or mood stabilizers (such as lithium or lamotrigine). Quetiapine effectively treats the depressive symptoms without carrying the high risk of inducing a manic switch that is associated with standard antidepressants.

Adım Adım Çözüm

1
Analyze the patient's current symptoms and duration.
The patient is experiencing a major depressive episode, characterized by 8 weeks of profound low mood, hypersomnia, and impaired concentration.
Establishing the current clinical syndrome is the first step in formulating a differential diagnosis.
2
Review the patient's past medical and psychiatric history.
The patient has a history of a discrete episode involving grandiosity, severe insomnia without fatigue, and disruptive behavior requiring hospitalization.
This historical event meets the full criteria for a manic episode, which changes the diagnosis from major depressive disorder to bipolar I disorder.
3
Evaluate the laboratory findings provided.
Both the TSH and free T4 levels fall within their respective normal reference ranges.
Normal thyroid function rules out an underlying endocrine etiology (such as hypothyroidism) for her depressive symptoms.
4
Select the safest and most effective pharmacotherapy for the established diagnosis.
Select an agent approved for bipolar depression, such as the atypical antipsychotic quetiapine.
In bipolar depression, standard antidepressant monotherapy must be avoided due to the risk of precipitating a manic switch. Mood stabilizers or specific atypical antipsychotics are indicated.

Anahtar Kavram

When evaluating a patient presenting with a major depressive episode, clinicians must meticulously screen for a history of mania or hypomania; the presence of a past manic episode confirms bipolar I disorder, requiring treatment with specific atypical antipsychotics or mood stabilizers rather than antidepressant monotherapy.
Soru 115Soru →

A 45-year-old woman is diagnosed with severe major depressive disorder without psychotic features. Place the following therapeutic interventions in the most appropriate chronological sequence of standard stepped-care escalation, assuming the patient exhibits an inadequate or partial response at each preceding step.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for escalating treatment in major depressive disorder is: 1) Initiate first-line monotherapy, 2) Switch to an alternative first-line agent or optimize dose, 3) Augment with a non-antidepressant agent, and 4) Refer for somatic therapies like ECT.
The stepped-care model for major depressive disorder emphasizes minimizing side effects and complexity early in treatment. First-line treatment is SSRI or SNRI monotherapy. If an adequate trial (at least 4-6 weeks at a therapeutic dose) fails, guidelines suggest switching to another antidepressant or adding a second antidepressant with a different mechanism. If multiple antidepressant trials fail, the depression is considered treatment-resistant, and augmentation with non-antidepressant medications (e.g., aripiprazole, lithium, thyroid hormone) is indicated. Finally, for highly refractory cases, interventional treatments like electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) are recommended as the final step in the sequence.

Adım Adım Çözüm

1
Identify the initial treatment of choice for major depressive disorder.
Monotherapy with an SSRI or SNRI is selected as the first step.
These medications have the best balance of efficacy and tolerability for initial treatment.
2
Determine the next step for a patient who does not respond to the initial trial.
Switching to another first-line agent or optimizing the dose is placed second.
Ensuring an adequate trial of monotherapy with different classes or agents is standard practice before utilizing multi-drug regimens.
3
Determine the step for managing treatment-resistant depression after multiple monotherapy failures.
Augmentation with an atypical antipsychotic or lithium is placed third.
Combining an antidepressant with an augmenting agent is indicated when initial monotherapy trials fail to achieve remission.
4
Identify the intervention for severe refractory depression.
Electroconvulsive therapy (ECT) is placed last.
ECT is highly effective but generally reserved for severe, treatment-resistant cases that have failed multiple psychopharmacologic interventions.

Anahtar Kavram

The stepped-care approach to major depressive disorder involves a progressive escalation from SSRI/SNRI monotherapy, to switching agents, to augmentation with non-antidepressants, and ultimately to neuromodulation like ECT for refractory cases.
Soru 116Soru →

For each of the following clinical scenarios involving a depressive presentation or its treatment, select the most appropriate next step in management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 74-year-old hospitalized patient with major depressive disorder who refuses all oral intake, exhibits profound psychomotor retardation, and repeatedly states that his internal organs are rotting.
A 32-year-old outpatient whose severe low mood remitted on fluoxetine, but who now presents with three days of decreased need for sleep, pressured speech, and reckless spending.
A 46-year-old outpatient whose feelings of worthlessness and anhedonia improved significantly on escitalopram, but who is now highly distressed by new-onset delayed ejaculation.
A 27-year-old primigravida at 9 weeks gestation presenting with a two-month history of mild fatigue, tearfulness, and low mood, with fully intact functional status and no suicidal ideation.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align life-threatening psychotic depression with electroconvulsive therapy, antidepressant-induced mania with stopping the SSRI and starting an antipsychotic, SSRI-induced sexual dysfunction with a switch to bupropion, and mild early-pregnancy depression with cognitive behavioral therapy.
Each clinical scenario presents a unique challenge in the treatment of depressive disorders. ECT provides the necessary rapid relief for life-threatening psychotic depression. Antidepressant-induced mania necessitates stopping the inciting SSRI and starting an antimanic agent. Bupropion avoids the serotonergic sexual side effects common with SSRIs. Psychotherapy is the safest starting point to avoid fetal medication exposure in mild perinatal depression.

Adım Adım Çözüm

1
Evaluate the 74-year-old patient with food refusal and delusions.
Identified as major depressive disorder with psychotic features and life-threatening poor intake.
Dictates the need for rapid, definitive somatic treatment because waiting for pharmacotherapy to take effect is unsafe.
2
Assess the 32-year-old patient exhibiting pressured speech and decreased sleep while on fluoxetine.
Identified as an acute manic episode precipitated by an antidepressant.
Requires immediate cessation of the provoking agent and initiation of primary mood-stabilizing treatment.
3
Address the 46-year-old patient's complaint of delayed ejaculation while taking escitalopram.
Identified as a common adverse effect of serotonergic therapy.
Prompts a switch to an effective antidepressant that does not primarily affect serotonin, such as bupropion.
4
Determine the optimal intervention for the 27-year-old pregnant patient with mild depression.
Identified psychotherapy as the safest and most appropriate first-line treatment.
Balances effective symptom management with fetal safety during the highly vulnerable first trimester of organogenesis.

Anahtar Kavram

The management of depressive disorders requires tailoring therapy to the specific clinical scenario: utilizing electroconvulsive therapy for life-threatening or psychotic depression, identifying and correctly managing medication-induced mania, mitigating specific adverse effects like sexual dysfunction, and employing non-pharmacologic options in high-risk populations such as early pregnancy.
ÖncekiSayfa 6 / 6